Randomised, double-blind, placebo-controlled trial of glycopyrronium in children and adolescents with severe sialorrhoea and neurodisabilities: protocol of the SALIVA trial

INTRODUCTION: Severe sialorrhoea is a common, distressing problem in children/adolescents with neurodisabilities, which has adverse health and social consequences. The SALIVA trial is designed to evaluate the efficacy and safety of a paediatric-specific oral solution of glycopyrronium along with its...

Descripción completa

Detalles Bibliográficos
Autores principales: Fayoux, Pierre, Dinomais, Mickael, Shaw, Helen, Probert, Nick, Villain, Frédéric, Pouchain, Denis, Texier, Nathalie, Auvin, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173983/
https://www.ncbi.nlm.nih.gov/pubmed/37156563
http://dx.doi.org/10.1136/bmjpo-2023-001913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173983/
https://www.ncbi.nlm.nih.gov/pubmed/37156563
http://dx.doi.org/10.1136/bmjpo-2023-001913

Ejemplares similares